101 related articles for article (PubMed ID: 15466164)
1. The roles of transporters and enzymes in hepatic drug processing.
Liu L; Pang KS
Drug Metab Dispos; 2005 Jan; 33(1):1-9. PubMed ID: 15466164
[TBL] [Abstract][Full Text] [Related]
2. Interplay of transporters and enzymes in drug and metabolite processing.
Pang KS; Maeng HJ; Fan J
Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
[TBL] [Abstract][Full Text] [Related]
3. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
4. Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes.
Lam JL; Benet LZ
Drug Metab Dispos; 2004 Nov; 32(11):1311-6. PubMed ID: 15483198
[TBL] [Abstract][Full Text] [Related]
5. An integrated approach to model hepatic drug clearance.
Liu L; Pang KS
Eur J Pharm Sci; 2006 Nov; 29(3-4):215-30. PubMed ID: 16806855
[TBL] [Abstract][Full Text] [Related]
6. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems.
Lau YY; Okochi H; Huang Y; Benet LZ
J Pharmacol Exp Ther; 2006 Feb; 316(2):762-71. PubMed ID: 16258024
[TBL] [Abstract][Full Text] [Related]
7. Effect of diffusional barriers on drug and metabolite kinetics.
de Lannoy IA; Pang KS
Drug Metab Dispos; 1987; 15(1):51-8. PubMed ID: 2881759
[TBL] [Abstract][Full Text] [Related]
8. A new model-independent physiological approach to study hepatic drug clearance and its applications.
Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes.
Fukuda H; Ohashi R; Tsuda-Tsukimoto M; Tamai I
Drug Metab Dispos; 2008 Jul; 36(7):1275-82. PubMed ID: 18388177
[TBL] [Abstract][Full Text] [Related]
10. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay.
Lau YY; Wu CY; Okochi H; Benet LZ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1040-5. PubMed ID: 14634033
[TBL] [Abstract][Full Text] [Related]
11. Effect of zonal transport and metabolism on hepatic removal: enalapril hydrolysis in zonal, isolated rat hepatocytes in vitro and correlation with perfusion data.
Abu-Zahra TN; Pang KS
Drug Metab Dispos; 2000 Jul; 28(7):807-13. PubMed ID: 10859155
[TBL] [Abstract][Full Text] [Related]
12. Vascular binding, blood flow, transporter, and enzyme interactions on the processing of digoxin in rat liver.
Liu L; Mak E; Tirona RG; Tan E; Novikoff PM; Wang P; Wolkoff AW; Pang KS
J Pharmacol Exp Ther; 2005 Oct; 315(1):433-48. PubMed ID: 15994370
[TBL] [Abstract][Full Text] [Related]
13. Altered nonrenal drug clearance in ESRD.
Nolin TD
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):555-9. PubMed ID: 18941346
[TBL] [Abstract][Full Text] [Related]
14. Increased estrogen sulfation of estradiol 17beta-D-glucuronide in metastatic tumor rat livers.
Sun H; Liu L; Pang KS
J Pharmacol Exp Ther; 2006 Nov; 319(2):818-31. PubMed ID: 16895976
[TBL] [Abstract][Full Text] [Related]
15. Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model.
Liu L; Sun H; Valji WY; Pang KS
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1078-88. PubMed ID: 17855765
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion.
Tahara H; Kusuhara H; Fuse E; Sugiyama Y
Drug Metab Dispos; 2005 Jul; 33(7):963-8. PubMed ID: 15821041
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans.
Matsushima S; Maeda K; Ishiguro N; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2008 Apr; 36(4):663-9. PubMed ID: 18180276
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
Soars MG; Webborn PJ; Riley RJ
Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
[TBL] [Abstract][Full Text] [Related]
19. Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis.
Tam D; Sun H; Pang KS
Drug Metab Dispos; 2003 Oct; 31(10):1214-26. PubMed ID: 12975330
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interplay of phase II metabolism and transport: a theoretical study.
Wu B
J Pharm Sci; 2012 Jan; 101(1):381-93. PubMed ID: 21905031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
